- IT 리더가 지목한 AI 가치 실현의 최대 걸림돌은 ‘비용 관리’
- Los CIO consideran que la gestión de costes puede acabar con el valor de la IA
- 칼럼 | AI 에이전트, 지금까지의 어떤 기술과도 다르다
- The $23 Echo Dot deal is a great deal to upgrade your smart home this Black Friday
- Amazon's Echo Spot smart alarm clock is almost half off this Black Friday
Despite adoption hurdles, healthcare is all-in on Generative AI
3) Use cases vary by technical experience and company size
GenAI’s applications in healthcare are diverse, with the most common uses being answering patient questions (21%), medical chatbots (20%), and information extraction/data abstraction (19%). Technical leaders, on the other hand, prioritize information extraction and biomedical research, indicating a strategic focus on gleaning data-driven insights and advancements.
Respondents foresee GenAI having the most significant impact on transcribing doctor-patient conversations, medical chatbots, and answering patient questions over the next few years. Smaller companies, in particular, have high expectations for these technologies, likely due to their agility and drive to gain a competitive edge.
4) Human intervention remains necessary
Accuracy, security, and privacy are paramount when evaluating LLMs, with Technical Leaders placing even greater emphasis on these criteria. The survey reveals that cost is the least important factor, suggesting a willingness to invest in high-quality, reliable models. Major roadblocks to adoption include concerns about accuracy, legal and reputational risks, and the technology’s alignment with industry-specific needs.